Skip to main content
. 2022 Nov 3;14(11):2370. doi: 10.3390/pharmaceutics14112370

Table 3.

Difference between eukaryotic-derived hEVs and gut-microbiota-derived bEVs.

Category Eukaryotic-Derived hEVs Gut-Microbiota-Derived bEVs
Biogenesis Generally produced from plasma membrane except exosomes, which originate from endocytic pathway Gram-negative bacteria: decreased protein linkages between the OM and peptidoglycan, accumulation of unfolded proteins and/or peptidoglycan in the periplasmic space, and explosive cell lysis
Gram-positive bacteria: turgor pressure by accumulation of bEVs and the action of cell-wall-degrading enzymes
Composition
(Cargo)
Multivesicular bodies composed of endosomal proteins; RNA and miRNA are regularly incorporated Proteins, peptidoglycans, lipids, LPS, lipoteichoic acids (LTA), nucleic acids, and metabolites
Major functions Intercellular communications (cell proliferation, matrix formation, and phagocytosis) Innate and adaptive immunity, bacterial communications, interaction with host miRNA for movement across intestinal barrier
Size 40–100 nm (exosomes) [124]; 500–2000 nm (apoptotic bodies) and 100–500 nm (microvesicles) [125] 10–300 nm [126]